Details for New Drug Application (NDA): 080778
✉ Email this page to a colleague
NDA 080778 describes ALPHAREDISOL, which is a drug marketed by Merck and is included in one NDA. Additional details are available on the ALPHAREDISOL profile page.
The generic ingredient in ALPHAREDISOL is hydroxocobalamin. There are four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the hydroxocobalamin profile page.
The generic ingredient in ALPHAREDISOL is hydroxocobalamin. There are four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the hydroxocobalamin profile page.
Summary for 080778
| Tradename: | ALPHAREDISOL |
| Applicant: | Merck |
| Ingredient: | hydroxocobalamin |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 080778
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 1MG/ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
